The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids

The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous s...

Full description

Saved in:
Bibliographic Details
Published in:Journal of internal medicine Vol. 294; no. 3; pp. 281 - 294
Main Authors: Bäckström, Torbjörn, Turkmen, Sahruh, Das, Roshni, Doverskog, Magnus, Blackburn, Thomas P.
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01.09.2023
Subjects:
ISSN:0954-6820, 1365-2796, 1365-2796
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA‐A receptor modulating stress and sex steroids (steroid‐PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA‐A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid‐PAMs and opportunities to treat these adverse effects of steroid‐PAMs with novel GAMSAs.
AbstractList The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA-A receptor modulating stress and sex steroids (steroid-PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA-A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid-PAMs and opportunities to treat these adverse effects of steroid-PAMs with novel GAMSAs.
The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA-A receptor modulating stress and sex steroids (steroid-PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA-A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid-PAMs and opportunities to treat these adverse effects of steroid-PAMs with novel GAMSAs.The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA-A receptor modulating stress and sex steroids (steroid-PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA-A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid-PAMs and opportunities to treat these adverse effects of steroid-PAMs with novel GAMSAs.
Author Turkmen, Sahruh
Bäckström, Torbjörn
Doverskog, Magnus
Das, Roshni
Blackburn, Thomas P.
Author_xml – sequence: 1
  givenname: Torbjörn
  orcidid: 0000-0002-0907-3535
  surname: Bäckström
  fullname: Bäckström, Torbjörn
  email: Torbjorn.c.backstrom@umu.se
  organization: University of Umeå
– sequence: 2
  givenname: Sahruh
  surname: Turkmen
  fullname: Turkmen, Sahruh
  organization: University of Umeå
– sequence: 3
  givenname: Roshni
  surname: Das
  fullname: Das, Roshni
  organization: Umecrine Cognition AB
– sequence: 4
  givenname: Magnus
  surname: Doverskog
  fullname: Doverskog, Magnus
  organization: Umecrine Cognition AB
– sequence: 5
  givenname: Thomas P.
  surname: Blackburn
  fullname: Blackburn, Thomas P.
  organization: Umecrine Cognition AB
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37518841$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-212756$$DView record from Swedish Publication Index (Umeå universitet)
BookMark eNp90c1u1DAUBWALFdFpYcMDIEtsECLFjvPjLNMCpaiom8LWunFuph4l8dR2GM2uD9En5EnwTEoXFcIbS9Z3j2yfI3Iw2hEJec3ZCY_r48qa4YSLkuXPyIKLIk_SsioOyIJVeZYUMmWH5Mj7FWNcsIK9IIeizLmUGV-Q2-sbpOf1aU391gccPlCgI25oALfEQDvr6ICt0RCMHT2FJZjRB6rtcjTB_EJqhjUYN-AYft_d195bbSBgSzcm3MSkyVnQexjTnTWtf0med9B7fPWwH5MfXz5fn31NLq_OL87qy0RngudJJ7JMQyElT6UukQko40nXaA4tsLIrMi5BtF1atbIDEIhZ1YiGpU1VYcZRHJNkzvUbXE-NWjszgNsqC0Z9Mj9rZd1STcOkUp6WeRH9u9mvnb2d0Ac1GK-x72FEO3mVyixjsmI5j_TtE7qykxvja3aqKtIoq6jePKipiX_4eIG_nx_B-xloZ7132D0SztSuWbVrVu2bjZg9wdqEfSvBgen_PcLnkY3pcfufcPXt6uL7PPMHztm3qg
CitedBy_id crossref_primary_10_1186_s13195_025_01797_5
crossref_primary_10_1007_s11064_025_04480_1
crossref_primary_10_1111_jnc_16087
crossref_primary_10_3390_biom14081022
crossref_primary_10_1016_j_physbeh_2025_114886
crossref_primary_10_1016_j_scib_2024_09_005
crossref_primary_10_1016_j_jsbmb_2025_106841
crossref_primary_10_1038_s41598_024_82913_7
crossref_primary_10_3389_fphar_2024_1491032
Cites_doi 10.1523/JNEUROSCI.1715-07.2007
10.1016/j.bbi.2016.02.001
10.1046/j.1365-201X.1998.0287f.x
10.1038/nrn3587
10.1016/j.neuropharm.2023.109530
10.1016/j.neuropharm.2003.11.029
10.1073/pnas.88.10.4553
10.1007/s00213-008-1150-7
10.1016/j.ejphar.2005.01.049
10.1126/science.2422758
10.1111/nan.12799
10.1016/j.neuroscience.2006.07.031
10.1007/s00213-005-0148-7
10.1111/cns.13926
10.1093/brain/awq116
10.1016/j.neuropharm.2008.07.045
10.1038/nrendo.2013.31
10.1016/S0887-6177(03)00096-9
10.2165/00003495-199142030-00003
10.1016/j.jsbmb.2004.12.001
10.1096/fj.05-4265fje
10.1016/j.yhbeh.2010.03.018
10.1016/S0006-8993(02)02414-9
10.1146/annurev.ne.17.030194.003033
10.1016/S0028-3908(02)00172-7
10.1016/j.nlm.2011.02.016
10.1016/0165-6147(92)90142-S
10.1016/j.yhbeh.2015.10.010
10.1016/0166-4328(96)00004-6
10.1126/science.290.5489.131
10.1016/j.neuint.2006.02.002
10.1016/j.pneurobio.2013.08.004
10.1038/s41398‐020‐01027‐6
10.3233/JAD-2012-120268
10.1016/S0006-8993(03)02939-1
10.1016/0306-4530(90)90025-5
10.1007/s00213-005-0254-6
10.1001/archgenpsychiatry.2010.61
10.1016/j.ynstr.2019.100206
10.1016/S0165-0173(01)00124-2
10.1016/j.neuroscience.2011.03.061
10.1016/0376-8716(87)90029-9
10.1007/s00213-011-2322-4
10.1016/S0301-0082(02)00013-8
10.1210/endo-81-2-369
10.1038/319774a0
10.1016/j.neuint.2011.10.003
10.1155/2022/3618090
10.1016/j.nlm.2010.01.002
10.1016/j.jalz.2011.03.001
10.1186/s40659-017-0130-y
10.1016/S0140-6736(18)31551-4
10.1124/jpet.110.169854
10.1016/j.jsbmb.2009.11.007
10.1016/0896-6273(90)90202-Q
10.1016/j.psyneuen.2009.08.011
10.1016/j.psyneuen.2019.05.028
10.1371/journal.pone.0024293
10.1124/pr.108.00505
10.1016/j.psyneuen.2004.08.003
10.3988/jcn.2008.4.3.99
10.1016/j.pnpbp.2004.06.001
10.1007/s00213-016-4258-1
10.1007/s40263-018-0535-3
10.1002/hipo.20790
10.1016/S0165-5728(98)00264-1
10.1001/jama.289.20.2651
10.1016/j.yfrne.2017.07.002
10.1016/j.coemr.2022.100359
10.1113/jphysiol.1992.sp019020
10.3389/fncel.2014.00115
10.1016/j.biopsycho.2004.08.003
10.1111/jgs.15358
10.2174/1568007033482779
10.1002/hep.1840110524
10.1016/j.neuint.2010.03.012
10.1097/00019052-199608000-00007
10.1523/JNEUROSCI.22-13-05572.2002
10.1111/j.1476-5381.2010.01059.x
10.1007/978-1-4615-5945-0_7
10.1016/j.pneurobio.2013.07.005
10.1111/bpa.12196
10.1111/j.1749-6632.1999.tb11341.x
10.1006/nlme.1999.3927
10.1016/j.ejphar.2007.11.071
10.1111/j.1530-0277.1995.tb01496.x
10.1016/j.psyneuen.2004.02.003
10.1016/j.jhep.2021.03.012
10.1016/0006-8993(95)01244-3
10.1111/j.1365-2982.2008.01132.x
10.1111/j.1600-0404.1984.tb07807.x
10.1016/S0074-7742(01)46066-1
10.1046/j.1471-4159.2000.0750732.x
10.1002/hbm.21502
10.1038/nrn1703
10.1053/j.gastro.2008.12.057
10.1016/j.bbi.2017.12.013
10.1016/j.psyneuen.2023.106054
10.1186/s43141‐021‐00224‐0
10.1023/A:1021949616422
10.1016/j.jalz.2017.02.001
10.1016/S0166-4328(01)00399-0
10.1021/jm00307a026
10.1371/journal.pone.0111136
10.1001/jama.285.11.1489
10.1152/ajpgi.00073
10.1007/s00213-018-4864-1
10.3390/biom12091262
10.1111/j.1748-1716.1987.tb08202.x
10.1016/0006-8993(93)91524-V
10.1111/j.1600-0773.1987.tb01770.x
10.1016/j.brainresrev.2005.11.001
10.1016/j.psyneuen.2022.105754
10.1212/01.wnl.0000339036.88842.9e
10.1046/j.1365-201x.2000.00744.x
10.1038/nature05324
10.1016/j.npep.2019.101937
10.1001/jama.291.24.2947
10.1016/j.pharmthera.2021.108048
10.1007/s00213-014-3776-y
10.1016/j.psyneuen.2012.10.014
10.1016/j.coph.2006.11.005
10.1001/jama.279.9.688
10.1111/j.1460-9568.2004.03610.x
10.1016/j.abb.2013.04.005
10.1111/bph.13843
10.1038/s41598-018-37409-6
10.1192/bjp.159.2.213
10.1111/apha.13270
10.1111/j.1365-2044.1990.tb14683.x
10.1515/revneuro-2014-0035
10.1016/S0006-8993(97)00455-1
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
– notice: 2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
ADHXS
ADTPV
AOWAS
D8T
D93
ZZAVC
DOI 10.1111/joim.13705
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SWEPUB Umeå universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Umeå universitet
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2796
EndPage 294
ExternalDocumentID oai_DiVA_org_umu_212756
37518841
10_1111_joim_13705
JOIM13705
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Stiftelsen J C Kempes Minnes Stipendiefond
  funderid: H2020; 721802
– fundername: Umectine Cognition AB
– fundername: Stiftelsen J C Kempes Minnes Stipendiefond
  grantid: H2020
– fundername: Stiftelsen J C Kempes Minnes Stipendiefond
  grantid: 721802
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SJN
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZCG
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
ADHXS
ADTPV
AOWAS
D8T
D93
ZZAVC
ID FETCH-LOGICAL-c4315-f344ca688128c7e03a7344fbc1ada07f6418a3df29d8faa3ee49b3b02b99e41e3
IEDL.DBID 24P
ISICitedReferencesCount 10
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001039236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0954-6820
1365-2796
IngestDate Tue Nov 04 16:49:40 EST 2025
Thu Sep 04 18:42:46 EDT 2025
Sun Nov 30 04:19:27 EST 2025
Thu Apr 03 07:06:21 EDT 2025
Sat Nov 29 01:51:27 EST 2025
Tue Nov 18 22:33:00 EST 2025
Wed Jan 22 16:20:51 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords dementia
allopregnanolone
memory
GABA-A receptor
neurosteroids
Language English
License Attribution
2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4315-f344ca688128c7e03a7344fbc1ada07f6418a3df29d8faa3ee49b3b02b99e41e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-0907-3535
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13705
PMID 37518841
PQID 2849624409
PQPubID 30713
PageCount 14
ParticipantIDs swepub_primary_oai_DiVA_org_umu_212756
proquest_miscellaneous_2844089051
proquest_journals_2849624409
pubmed_primary_37518841
crossref_primary_10_1111_joim_13705
crossref_citationtrail_10_1111_joim_13705
wiley_primary_10_1111_joim_13705_JOIM13705
PublicationCentury 2000
PublicationDate September 2023
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: September 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Journal of internal medicine
PublicationTitleAlternate J Intern Med
PublicationYear 2023
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2002; 17
2004; 20
2004; 29
1984; 69
2004; 28
2014; 25
2022; 25
2015; 309
2014; 24
2020; 12
2011; 191
1998; 279
1999; 288
1996; 79
2008; 583
2001; 46
2022; 28
2018; 48
2013; 9
2005; 69
2017; 72
2010; 21
2006; 20
2021; 75
1990; 45
2004; 291
2010; 118
1991; 88
1997; 420
2007; 7
2008; 20
2008; 199
2018; 32
2003; 289
1998; 162
2006; 444
2019; 9
2001; 285
2010; 35
2006; 51
2002; 132
2017; 69
1986; 232
2005; 512
2004; 46
2000; 73
2019; 226
2019; 108
2002; 934
2011; 6
2012; 31
2022; 234
1999; 868
2017; 50
1987; 61
2023; 151
2009; 72
2002; 67
2010; 334
2006; 49
1995; 705
2000; 75
2018; 235
2022; 12
2005; 6
2006; 186
2001; 37
2005; 93
1994; 17
2003; 982
1990; 4
2012; 60
1993; 607
1990; 11
2010; 58
2010; 57
1990; 15
2011; 96
1992; 447
1992; 13
2008; 4
1991; 159
2000; 290
2016; 78
2010; 67
2009; 56
2014; 5
2013; 14
2013; 10
2000; 169
1991; 42
2002; 43
2003; 2
2005; 30
2016; 233
1999; 96
1998; 50
2014; 9
2011; 162
2008; 60
1996; 9
1968; 11
2007; 27
1987; 241
1967; 81
2011; 218
2019; 76
2016; 54
2020; 349
1994; 46
2022; 48
2017; 174
1995; 19
2018; 66
2009; 136
1986; 319
2014; 113
1987; 131
1997; 764
1987; 20
2022; 141
2022; 2022
2013; 38
2018; 392
2004; 19
2013; 34
2023; 233
2017; 13
2013; 536
2021; 19
2002; 22
2010; 133
2006; 143
2012; 8
2010; 93
e_1_2_19_26_1
e_1_2_19_49_1
e_1_2_19_41_1
e_1_2_19_68_1
e_1_2_19_22_1
e_1_2_19_45_1
e_1_2_19_64_1
e_1_2_19_87_1
e_1_2_19_60_1
e_1_2_19_83_1
e_1_2_19_129_1
e_1_2_19_7_1
e_1_2_19_106_1
e_1_2_19_125_1
e_1_2_19_3_1
e_1_2_19_102_1
e_1_2_19_121_1
e_1_2_19_15_1
e_1_2_19_38_1
e_1_2_19_19_1
e_1_2_19_53_1
e_1_2_19_99_1
e_1_2_19_30_1
e_1_2_19_11_1
e_1_2_19_57_1
e_1_2_19_95_1
e_1_2_19_34_1
e_1_2_19_76_1
e_1_2_19_91_1
e_1_2_19_72_1
e_1_2_19_118_1
e_1_2_19_114_1
e_1_2_19_137_1
Bengtsson SK (e_1_2_19_94_1) 2013; 10
e_1_2_19_110_1
e_1_2_19_133_1
e_1_2_19_29_1
e_1_2_19_48_1
e_1_2_19_67_1
e_1_2_19_40_1
e_1_2_19_25_1
e_1_2_19_63_1
e_1_2_19_44_1
e_1_2_19_86_1
e_1_2_19_82_1
e_1_2_19_107_1
e_1_2_19_6_1
e_1_2_19_103_1
e_1_2_19_126_1
Harrison NL (e_1_2_19_139_1) 1987; 241
e_1_2_19_2_1
e_1_2_19_122_1
e_1_2_19_18_1
e_1_2_19_10_1
e_1_2_19_52_1
e_1_2_19_79_1
e_1_2_19_14_1
e_1_2_19_33_1
e_1_2_19_56_1
e_1_2_19_75_1
e_1_2_19_98_1
e_1_2_19_71_1
e_1_2_19_90_1
e_1_2_19_119_1
e_1_2_19_138_1
e_1_2_19_115_1
e_1_2_19_134_1
Kokate TG (e_1_2_19_88_1) 1999; 288
e_1_2_19_111_1
e_1_2_19_28_1
e_1_2_19_130_1
e_1_2_19_20_1
e_1_2_19_43_1
e_1_2_19_66_1
e_1_2_19_89_1
e_1_2_19_24_1
e_1_2_19_62_1
e_1_2_19_85_1
e_1_2_19_81_1
e_1_2_19_9_1
e_1_2_19_108_1
e_1_2_19_127_1
e_1_2_19_5_1
Sindi S (e_1_2_19_21_1) 2017; 72
e_1_2_19_104_1
e_1_2_19_123_1
e_1_2_19_100_1
e_1_2_19_17_1
e_1_2_19_59_1
e_1_2_19_32_1
e_1_2_19_78_1
e_1_2_19_51_1
e_1_2_19_36_1
e_1_2_19_74_1
e_1_2_19_13_1
e_1_2_19_55_1
e_1_2_19_97_1
e_1_2_19_70_1
e_1_2_19_93_1
e_1_2_19_116_1
e_1_2_19_112_1
e_1_2_19_135_1
e_1_2_19_131_1
e_1_2_19_27_1
e_1_2_19_42_1
e_1_2_19_69_1
e_1_2_19_46_1
e_1_2_19_84_1
e_1_2_19_23_1
e_1_2_19_65_1
e_1_2_19_80_1
e_1_2_19_61_1
e_1_2_19_109_1
Barnard EA (e_1_2_19_37_1) 1998; 50
e_1_2_19_8_1
Hawkinson JE (e_1_2_19_47_1) 1994; 46
e_1_2_19_105_1
e_1_2_19_128_1
e_1_2_19_4_1
e_1_2_19_101_1
e_1_2_19_124_1
e_1_2_19_16_1
e_1_2_19_39_1
e_1_2_19_120_1
e_1_2_19_31_1
e_1_2_19_54_1
e_1_2_19_77_1
e_1_2_19_12_1
e_1_2_19_35_1
e_1_2_19_58_1
e_1_2_19_73_1
e_1_2_19_96_1
e_1_2_19_92_1
e_1_2_19_50_1
e_1_2_19_117_1
e_1_2_19_136_1
e_1_2_19_113_1
e_1_2_19_132_1
References_xml – volume: 81
  start-page: 369
  issue: 2
  year: 1967
  end-page: 74
  article-title: Relationship between the anesthetic and gestagenic action and estrous behavior‐inducing activity of different progestins
  publication-title: Endocrinology.
– volume: 2
  start-page: 233
  issue: 4
  year: 2003
  end-page: 9
  article-title: GABA(A) receptor subtype selective cognition enhancers
  publication-title: Curr Drug Targets CNS Neurol Disord.
– volume: 46
  start-page: 977
  issue: 5
  year: 1994
  end-page: 85
  article-title: Correlation of neuroactive steroid modulation of [35S]t‐butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma‐aminobutyric acidA receptor function
  publication-title: Mol Pharmacol.
– volume: 151
  year: 2023
  article-title: Rapid effects of acute stress on cognitive emotion regulation
  publication-title: Psychoneuroendocrinology.
– volume: 50
  start-page: 291
  issue: 2
  year: 1998
  end-page: 314
  article-title: International Union of Pharmacology. XV. Subtypes of γ‐aminobutyric AcidA receptors: classification on the basis of subunit structure and receptor function
  publication-title: Pharmacol Rev.
– volume: 199
  start-page: 161
  issue: 2
  year: 2008
  end-page: 8
  article-title: Allopregnanolone impairs episodic memory in healthy women
  publication-title: Psychopharmacology (Berl).
– volume: 58
  start-page: 200
  year: 2010
  end-page: 7
  article-title: Effects of long‐term treatment with 17 β‐estradiol and medroxyprogesterone acetate on water maze performance in middle‐aged female rats
  publication-title: Horm Behav.
– volume: 25
  start-page: 785
  issue: 6
  year: 2014
  end-page: 804
  article-title: Chronic stress as a risk factor for Alzheimer's disease
  publication-title: Rev Neurosci.
– volume: 57
  start-page: 383
  issue: 4
  year: 2010
  end-page: 8
  article-title: Altered glial‐neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy
  publication-title: Neurochem Int.
– volume: 34
  start-page: 1187
  issue: 5
  year: 2013
  end-page: 93
  article-title: Menstrual cycle‐related changes in amygdala morphology are associated with changes in stress sensitivity
  publication-title: Hum Brain Mapp.
– volume: 93
  start-page: 305
  issue: 2–5
  year: 2005
  end-page: 8
  article-title: Progestins and estrogens and Alzheimer's disease
  publication-title: J Steroid Biochem Mol Biol.
– volume: 66
  start-page: 1123
  issue: 6
  year: 2018
  end-page: 9
  article-title: Use of antiepileptic drugs and dementia risk—an analysis of Finnish health register and German health insurance data
  publication-title: J Am Geriatr Soc.
– volume: 10
  start-page: 38
  issue: 1
  year: 2013
  end-page: 47
  article-title: Brief but chronic increase in allopregnanolone causes accelerated AD pathology differently in two mouse models
  publication-title: Curr Alzheimer Res.
– volume: 186
  start-page: 402
  issue: 3
  year: 2006
  article-title: Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age‐related changes
  publication-title: Psychopharmacology (Berl).
– volume: 20
  start-page: 203
  issue: 3
  year: 1987
  end-page: 12
  article-title: Impaired performance of rats in the Morris swim‐maize test late in abstinence following long‐term sodium barbital treatment
  publication-title: Drug Alcohol Depend.
– volume: 49
  start-page: 372
  issue: 4
  year: 2006
  end-page: 8
  article-title: Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma
  publication-title: Neurochem Int.
– volume: 50
  start-page: 1
  issue: 1
  year: 2017
  end-page: 11
  article-title: Neuron‐derived CCL2 contributes to microglia activation and neurological decline in hepatic encephalopathy
  publication-title: Biol Res.
– volume: 309
  start-page: G400
  year: 2015
  end-page: 9
  article-title: GR3027 antagonizes GABAA receptor‐potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy
  publication-title: Am J Physiol Gastrointest Liver Physiol.
– volume: 9
  start-page: 241
  issue: 4
  year: 2013
  end-page: 50
  article-title: Neurosteroids as regenerative agents in the brain: therapeutic implications
  publication-title: Nat Rev Endocrinol.
– volume: 4
  start-page: 759
  issue: 5
  year: 1990
  end-page: 65
  article-title: Neurosteroids act on recombinant human GABAA receptors
  publication-title: Neuron.
– volume: 233
  year: 2023
  article-title: Pre‐ and postsynaptic modulation of hippocampal inhibitory synaptic transmission by pregnenolone sulphate
  publication-title: Neuropharmacology.
– volume: 349
  start-page: 1
  year: 2020
  end-page: 11
  article-title: Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on?
  publication-title: Transl Psychiatry.
– volume: 11
  start-page: 117
  year: 1968
  end-page: 25
  article-title: Structure‐activity relationship of some steroidal hypnotic agents
  publication-title: J Med Chem.
– volume: 78
  start-page: 160
  year: 2016
  end-page: 7
  article-title: Long‐term continuous allopregnanolone elevation causes memory decline and hippocampus shrinkage, in female wildtype B6 mice
  publication-title: Horm Behav.
– volume: 51
  start-page: 212
  issue: 2
  year: 2006
  end-page: 39
  article-title: Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
  publication-title: Brain Res Rev.
– volume: 512
  start-page: 15
  year: 2005
  end-page: 21
  article-title: Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats
  publication-title: Eur J Pharmacol.
– volume: 61
  start-page: 42
  issue: 1
  year: 1987
  end-page: 7
  article-title: The anaesthetic potency of 3 alpha‐hydroxy‐5 alpha‐pregnan‐20‐one and 3 alpha‐hydroxy‐5 beta‐pregnan‐20‐one determined with an intravenous EEG‐threshold method in male rats
  publication-title: Pharmacol Toxicol.
– volume: 233
  start-page: 2109
  issue: 11
  year: 2016
  end-page: 17
  article-title: Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study
  publication-title: Psychopharmacology (Berl).
– volume: 93
  start-page: 444
  issue: 3
  year: 2010
  end-page: 53
  article-title: Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats
  publication-title: Neurobiol Learn Mem.
– volume: 17
  start-page: 569
  year: 1994
  end-page: 602
  article-title: GABAA receptor channels
  publication-title: Annu Rev Neurosci.
– volume: 11
  start-page: 874
  issue: 5
  year: 1990
  end-page: 8
  article-title: Increased densities of peripheral‐type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy
  publication-title: Hepatology.
– volume: 15
  start-page: 159
  year: 1990
  end-page: 62
  article-title: Regional distribution of progesterone and 5a‐pregnane‐3,20‐dione in rat brain during progesterone induced anesthesia
  publication-title: Psychoneuroendocrinology.
– volume: 232
  start-page: 1004
  issue: 4753
  year: 1986
  end-page: 7
  article-title: Steroid hormone metabolites are barbiturate‐like modulators of the GABA receptor
  publication-title: Science.
– volume: 25
  year: 2022
  article-title: Pleiotropic endophenotypic and phenotype effects of GABAergic neurosteroid synthesis deficiency in posttraumatic stress disorder
  publication-title: Curr Opin Endocr Metab Res.
– volume: 9
  start-page: 281
  issue: 4
  year: 1996
  end-page: 5
  article-title: Spectrum of memory dysfunction in degenerative disease
  publication-title: Curr Opin Neurol.
– volume: 141
  year: 2022
  article-title: Medroxyprogesterone acetate positively modulates specific GABA ‐receptor subtypes—affecting memory and cognition
  publication-title: Psychoneuroendocrinology.
– volume: 136
  start-page: 1359
  issue: 4
  year: 2009
  end-page: 67
  article-title: Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex
  publication-title: Gastroenterology.
– volume: 76
  year: 2019
  article-title: The additive effect of allopregnanolone on ghrelin's orexigenic effect in rats
  publication-title: Neuropeptides.
– volume: 29
  start-page: 1341
  year: 2004
  end-page: 4
  article-title: Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptors
  publication-title: Psychoneuroendocrinology.
– volume: 67
  start-page: 608
  issue: 6
  year: 2010
  end-page: 13
  article-title: Posttraumatic stress disorder and risk of dementia among US veterans
  publication-title: Arch Gen Psychiatry.
– volume: 60
  start-page: 243
  year: 2008
  end-page: 60
  article-title: International Union of Pharmacology. LXX. Subtypes of γ‐aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function
  publication-title: Pharmacol Rev.
– volume: 226
  issue: 2
  year: 2019
  article-title: Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: underlying mechanisms and therapeutic implications
  publication-title: Acta Physiol.
– volume: 241
  start-page: 346
  issue: 1
  year: 1987
  end-page: 53
  article-title: Structure‐activity relationships for steroid interaction with the GABA‐A receptor complex
  publication-title: J Pharmacol Exp Ther.
– volume: 46
  start-page: 856
  issue: 6
  year: 2004
  end-page: 64
  article-title: Characterization of the convulsant action of pregnenolone sulfate
  publication-title: Neuropharmacology.
– volume: 54
  start-page: 260
  year: 2016
  end-page: 77
  article-title: Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro‐immune interactions
  publication-title: Brain Behav Immun.
– volume: 43
  start-page: 651
  issue: 4
  year: 2002
  end-page: 61
  article-title: The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors
  publication-title: Neuropharmacology.
– volume: 13
  start-page: 446
  issue: 12
  year: 1992
  end-page: 50
  article-title: GABAA receptors: ligand‐gated Cl‐ ion channels modulated by multiple drug‐binding sites
  publication-title: Trends Pharmacol Sci.
– volume: 447
  start-page: 587
  year: 1992
  end-page: 625
  article-title: A novel modulatory binding site for zinc on the GABAA receptor complex in cultured rat neurones
  publication-title: J Physiol.
– volume: 7
  start-page: 93
  year: 2007
  end-page: 9
  article-title: Altered chloride homeostasis in neurological disorders: a new target
  publication-title: Curr Opin Pharmacol.
– volume: 186
  start-page: 414
  issue: 3
  year: 2006
  end-page: 24
  article-title: Pharmacodynamic effects of allopregnanolone in healthy women
  publication-title: Psychopharmacology (Berl).
– volume: 27
  start-page: 11416
  issue: 42
  year: 2007
  end-page: 23
  article-title: How progesterone impairs memory for biologically salient stimuli in healthy young women
  publication-title: J Neurosci.
– volume: 19
  start-page: 226
  issue: 1
  year: 1995
  end-page: 32
  article-title: Ethanol increases GABAA responses in cells stably transfected with receptor subunits
  publication-title: Alcohol Clin Exp Res.
– volume: 583
  start-page: 174
  issue: 2–3
  year: 2008
  end-page: 85
  article-title: Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators
  publication-title: Eur J Pharmacol.
– volume: 8
  start-page: 114
  issue: 2
  year: 2012
  end-page: 20
  article-title: Psychosocial stress at work is associated with increased dementia risk in late life
  publication-title: Alzheimer's Dement.
– volume: 392
  start-page: 1058
  year: 2018
  end-page: 70
  article-title: Brexanolone injection in post‐partum depression: two multicentre, double‐blind, randomised, placebo‐controlled, phase 3 trials
  publication-title: Lancet.
– volume: 42
  start-page: 365
  issue: 3
  year: 1991
  end-page: 78
  article-title: The clinical use of barbiturates in neurological disorders
  publication-title: Drugs.
– volume: 279
  start-page: 688
  year: 1998
  end-page: 95
  article-title: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia
  publication-title: JAMA.
– volume: 14
  start-page: 851
  issue: 12
  year: 2013
  end-page: 8
  article-title: Hepatic encephalopathy: effects of liver failure on brain function
  publication-title: Nat Rev Neurosci.
– volume: 5
  start-page: 1
  year: 2014
  end-page: 7
  article-title: CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles
  publication-title: Front Cell Neurosci.
– volume: 291
  start-page: 2947
  issue: 24
  year: 2004
  end-page: 58
  article-title: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women
  publication-title: JAMA.
– volume: 169
  start-page: 333
  issue: 4
  year: 2000
  end-page: 41
  article-title: The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone
  publication-title: Acta Physiol Scand.
– volume: 12
  start-page: 1262
  year: 2022
  article-title: The allopregnanolone response to acute stress in females: preclinical and clinical studies
  publication-title: Biomolecules.
– volume: 162
  start-page: 311
  year: 2011
  end-page: 27
  article-title: Tolerance to allopregnanolone with focus on the GABA‐A receptor
  publication-title: Br J Pharmacol.
– volume: 37
  start-page: 68
  issue: 1–3
  year: 2001
  end-page: 80
  article-title: Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids
  publication-title: Brain Res Brain Res Rev.
– volume: 131
  start-page: 33
  year: 1987
  end-page: 42
  article-title: The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cortex
  publication-title: Acta Physiol Scand.
– volume: 4
  start-page: 99
  issue: 3
  year: 2008
  end-page: 106
  article-title: Cognitive effects of antiepileptic drugs
  publication-title: J Clin Neurol.
– volume: 2022
  start-page: 1
  year: 2022
  end-page: 13
  article-title: Neurosteroid activation of GABA receptors: a potential treatment target for symptoms in primary biliary cholangitis?
  publication-title: Can J Gastroenterol Hepatol.
– volume: 21
  start-page: 724
  issue: 7
  year: 2010
  end-page: 32
  article-title: Chronic psychosocial stress accelerates impairment of long‐term memory and late‐phase long‐term potentiation in an at‐risk model of Alzheimer's disease
  publication-title: Hippocampus.
– volume: 45
  start-page: 189
  year: 1990
  end-page: 97
  article-title: Pregnanolone emulsion: A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent
  publication-title: Anaesthesia.
– volume: 75
  start-page: 98
  issue: 1
  year: 2021
  end-page: 107
  article-title: A pilot study of golexanolone, a new GABA receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy
  publication-title: J Hepatol.
– volume: 290
  start-page: 131
  year: 2000
  end-page: 4
  article-title: Molecular and neuronal substrate for the selective attenuation of anxiety
  publication-title: Science.
– volume: 73
  start-page: 150
  issue: 2
  year: 2000
  end-page: 67
  article-title: The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus
  publication-title: Neurobiol Learn Mem.
– volume: 72
  start-page: 125
  issue: 2
  year: 2009
  end-page: 34
  article-title: Postmenopausal hormone therapy and subclinical cerebrovascular disease
  publication-title: Neurology.
– volume: 28
  start-page: 1861
  issue: 11
  year: 2022
  end-page: 74
  article-title: Golexanolone, a GABA receptor modulating steroid antagonist, restores motor coordination and cognitive function in hyperammonemic rats by dual effects on peripheral inflammation and neuroinflammation
  publication-title: CNS Neurosci Ther.
– volume: 764
  start-page: 173
  year: 1997
  end-page: 8
  article-title: Progesterone, 5α‐pregnane‐3,20‐dione and 3αhydroxy‐5α‐pregnane‐20‐one in specific regions of the human female brain at different endocrine states
  publication-title: Brain Res.
– volume: 6
  issue: 8
  year: 2011
  article-title: Allopregnanolone promotes regeneration and reduces β‐amyloid burden in a preclinical model of Alzheimer's disease
  publication-title: PLoS One.
– volume: 19
  start-page: 437
  issue: 3
  year: 2004
  end-page: 54
  article-title: Persistence of cognitive effects after withdrawal from long‐term benzodiazepine use: a meta‐analysis
  publication-title: Arch Clin Neuropsychol.
– volume: 218
  start-page: 405
  issue: 2
  year: 2011
  end-page: 18
  article-title: Cognitive‐impairing effects of medroxyprogesterone acetate in the rat: independent and interactive effects across time
  publication-title: Psychopharmacology (Berl).
– volume: 233
  start-page: 2025
  issue: 11
  year: 2016
  end-page: 33
  article-title: Women with PTSD have a changed sensitivity to GABA receptor active substances
  publication-title: Psychopharmacology (Berl).
– volume: 28
  start-page: 1029
  issue: 6
  year: 2004
  end-page: 34
  article-title: Effects of the active neurosteroid allotetrahydrodeoxycorticosterone on long‐term potentiation in the rat hippocampus: implications for depression
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry.
– volume: 934
  start-page: 125
  issue: 2
  year: 2002
  end-page: 31
  article-title: Allopregnanolone inhibits learning in the Morris water maze
  publication-title: Brain Res.
– volume: 69
  start-page: 240
  year: 1984
  end-page: 8
  article-title: Effects of continuous progesterone infusion on the epileptic discharge frequency in women with partial epilepsy
  publication-title: Acta Neurol Scand.
– volume: 288
  start-page: 679
  issue: 2
  year: 1999
  end-page: 84
  article-title: Finasteride, a 5alpha‐reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice
  publication-title: J Pharmacol Exp Ther.
– volume: 13
  start-page: 325
  year: 2017
  end-page: 73
  article-title: Alzheimer's disease facts and Figs
  publication-title: Alzheimer's Dement.
– volume: 9
  issue: 10
  year: 2014
  article-title: Identifying risk factors for PTSD in women seeking medical help after rape
  publication-title: PLoS One.
– volume: 143
  start-page: 73
  issue: 1
  year: 2006
  end-page: 81
  article-title: Neurosteroid modulation of allopregnanolone and GABA effect on the GABA receptor
  publication-title: Neuroscience.
– volume: 69
  start-page: 271
  issue: 3
  year: 2005
  end-page: 9
  article-title: Impaired cognitive performance in patients with chronic burnout syndrome
  publication-title: Biol Psychol.
– volume: 69
  start-page: 386
  year: 2017
  end-page: 98
  article-title: Increasing extracellular cGMP in cerebellum in vivo reduces neuroinflammation, GABAergic tone and motor in‐coordination in hyperammonemic rats
  publication-title: Brain Behav Immun.
– volume: 113
  start-page: 40
  year: 2014
  end-page: 55
  article-title: Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise
  publication-title: Prog Neurobiol.
– volume: 31
  start-page: 71
  issue: 1
  year: 2012
  end-page: 84
  article-title: Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPPSwePSEN1ΔE9 mice
  publication-title: J Alzheimers Dis.
– volume: 6
  start-page: 565
  issue: 7
  year: 2005
  end-page: 75
  article-title: Neurosteroids: endogenous regulators of the GABA(A) receptor
  publication-title: Nat Rev Neurosci.
– volume: 24
  start-page: 631
  issue: 6
  year: 2014
  end-page: 53
  article-title: The 18 kDa translocator protein, microglia and neuroinflammation
  publication-title: Brain Pathol.
– volume: 20
  start-page: 729
  issue: 6
  year: 2006
  end-page: 51
  article-title: Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I‐CT100 transgenic mice, an Alzheimer's disease model
  publication-title: FASEB J.
– volume: 38
  start-page: 1078
  issue: 7
  year: 2013
  end-page: 89
  article-title: Increased neurosteroid sensitivity—an explanation to symptoms associated with chronic work‐related stress in women?
  publication-title: Psychoneuroendocrinology.
– volume: 96
  start-page: 21
  issue: 1
  year: 1999
  end-page: 8
  article-title: GABA(A) receptors mediate inhibition of T cell responses
  publication-title: J Neuroimmunol.
– volume: 174
  start-page: 3226
  issue: 19
  year: 2017
  end-page: 41
  article-title: Neurosteroid biosynthesis down‐regulation and changes in GABAA receptor subunit composition: a biomarker axis in stress‐induced cognitive and emotional impairment
  publication-title: Br J Pharmacol.
– volume: 607
  start-page: 324
  issue: 1–2
  year: 1993
  end-page: 8
  article-title: Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat
  publication-title: Brain Res.
– volume: 191
  start-page: 46
  year: 2011
  end-page: 54
  article-title: Paradoxical effects of GABA‐A modulators may explain sex steroid induced negative mood symptoms in some persons
  publication-title: Neuroscience.
– volume: 159
  start-page: 213
  year: 1991
  end-page: 6
  article-title: Heavy drinking as a risk factor for depression and dementia in elderly men. Findings from the Liverpool longitudinal community study
  publication-title: Br J Psychiatry.
– volume: 113
  start-page: 88
  year: 2014
  end-page: 94
  article-title: Allopregnanolone and mood disorders
  publication-title: Prog Neurobiol.
– volume: 235
  start-page: 1533
  issue: 5
  year: 2018
  end-page: 43
  article-title: GR3027 reversal of neurosteroid‐induced, GABA receptor‐mediated inhibition of human brain function: an allopregnanolone challenge study
  publication-title: Psychopharmacology (Berl).
– volume: 75
  start-page: 732
  issue: 2
  year: 2000
  end-page: 40
  article-title: Social isolation‐induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain
  publication-title: J Neurochem.
– volume: 56
  start-page: 141
  issue: 1
  year: 2009
  end-page: 8
  article-title: GABA A receptors: subtypes provide diversity of function and pharmacology
  publication-title: Neuropharmacology.
– volume: 48
  start-page: 70
  year: 2018
  end-page: 7
  article-title: Allopregnanolone involvement in feeding regulation, overeating and obesity
  publication-title: Front Neuroendocrinol.
– volume: 17
  start-page: 275
  issue: 4
  year: 2002
  end-page: 81
  article-title: Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy
  publication-title: Metab Brain Dis.
– volume: 9
  start-page: 1
  issue: 1
  year: 2019
  end-page: 14
  article-title: Endogenous neurosteroid 3α,5α‐hydroxypregnan‐20‐one inhibits toll‐like‐4 receptor activation and pro‐inflammatory signaling in macrophages and brain
  publication-title: Sci Rep.
– volume: 79
  start-page: 109
  issue: 1–2
  year: 1996
  end-page: 18
  article-title: Behavioral effects of 3 alpha‐androstanediol. I: Modulation of sexual receptivity and promotion of GABA‐stimulated chloride flux
  publication-title: Behav Brain Res.
– volume: 536
  start-page: 122
  issue: 2
  year: 2013
  end-page: 30
  article-title: GABAergic transmission in hepatic encephalopathy
  publication-title: Arch Biochem Biophys.
– volume: 420
  start-page: 95
  year: 1997
  end-page: 111
  article-title: The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy
  publication-title: Adv Exp Med Biol.
– volume: 32
  start-page: 485
  issue: 6
  year: 2018
  end-page: 97
  article-title: A systematic review and meta‐analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias
  publication-title: CNS Drugs.
– volume: 118
  start-page: 304
  issue: 4–5
  year: 2010
  end-page: 10
  article-title: Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS)
  publication-title: J Steroid Biochem Mol Biol.
– volume: 133
  start-page: 2217
  issue: 8
  year: 2010
  end-page: 24
  article-title: Midlife psychological stress and risk of dementia: a 35‐year longitudinal population study
  publication-title: Brain.
– volume: 234
  year: 2022
  article-title: Imaging neuroinflammation with TSPO: a new perspective on cellular sources and subcellular localization
  publication-title: Pharmacol Ther.
– volume: 67
  start-page: 113
  issue: 2
  year: 2002
  end-page: 59
  article-title: Drug interactions at GABA(A) receptors
  publication-title: Prog Neurobiol.
– volume: 88
  start-page: 4553
  issue: 10
  year: 1991
  end-page: 7
  article-title: Stress‐induced elevations of γ‐aminobutyric acid type A receptor‐active steroids in the rat brain
  publication-title: Proc Natl Acad Sci USA.
– volume: 319
  start-page: 774
  year: 1986
  end-page: 6
  article-title: Selective impairment of learning and blockade of long‐term potentiation by an N‐methyl‐D‐aspartate receptor antagonist, AP5
  publication-title: Nature.
– volume: 285
  start-page: 1489
  year: 2001
  end-page: 99
  article-title: Hormone replacement therapy and cognition: systematic review and meta‐analysis
  publication-title: JAMA.
– volume: 20
  start-page: 1604
  year: 2004
  end-page: 12
  article-title: 3beta‐20beta‐dihydroxy‐5alpha‐pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone
  publication-title: Eur J Neurosci.
– volume: 19
  start-page: 123
  year: 2021
  article-title: GABAA receptors: structure, function, pharmacology, and related disorders
  publication-title: J Genet Eng Biotechnol.
– volume: 108
  start-page: 94
  year: 2019
  end-page: 101
  article-title: Clinical characterization of allostatic overload
  publication-title: Psychoneuroendocrinology.
– volume: 982
  start-page: 45
  year: 2003
  end-page: 53
  article-title: Allopregnanolone‐stimulated GABA‐mediated chloride ion flux is inhibited by 3β‐hydroxy‐5α‐pregnan‐20‐one (isoallopregnanolone)
  publication-title: Brain Res.
– volume: 162
  start-page: 77
  issue: 1
  year: 1998
  end-page: 88
  article-title: Interaction between 3 alpha‐hydroxy‐5 alpha‐pregnan‐20‐one and carbachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrus
  publication-title: Acta Physiol Scand.
– volume: 22
  start-page: 5572
  issue: 13
  year: 2002
  end-page: 80
  article-title: Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABA receptor
  publication-title: J Neurosci.
– volume: 60
  start-page: 707
  issue: 7
  year: 2012
  end-page: 14
  article-title: GABAergic neurosteroids: the “endogenous benzodiazepines” of acute liver failure
  publication-title: Neurochem Int.
– volume: 35
  start-page: 47
  issue: 1
  year: 2010
  end-page: 55
  article-title: Neural mechanisms underlying changes in stress‐sensitivity across the menstrual cycle
  publication-title: Psychoneuroendocrinology.
– volume: 72
  start-page: 1044
  issue: 6
  year: 2017
  end-page: 53
  article-title: Midlife work‐related stress increases dementia risk in later life: the CAIDE 30‐year study
  publication-title: J Gerontol B Psychol Sci Soc Sci.
– volume: 334
  start-page: 1031
  issue: 3
  year: 2010
  end-page: 41
  article-title: The testosterone‐derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors
  publication-title: Pharmacol Exp Ther.
– volume: 20
  start-page: 949
  issue: 8
  year: 2008
  end-page: 57
  article-title: Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis
  publication-title: Neurogastroenterol Motil.
– volume: 46
  start-page: 273
  year: 2001
  end-page: 320
  article-title: Neurosteroids in learning and memory processes
  publication-title: Int Rev Neurobiol.
– volume: 12
  year: 2020
  article-title: GABA receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia
  publication-title: Neurobiol Stress.
– volume: 132
  start-page: 77
  issue: 1
  year: 2002
  end-page: 84
  article-title: Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task
  publication-title: Behav Brain Res.
– volume: 868
  start-page: 645
  year: 1999
  end-page: 53
  article-title: Molecular and functional diversity of the expanding GABA receptor gene family
  publication-title: Ann NY Acad Sci.
– volume: 705
  start-page: 345
  issue: 1–2
  year: 1995
  end-page: 8
  article-title: Acute liver failure and hyperammonemia increase peripheral‐type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain
  publication-title: Brain Res.
– volume: 96
  start-page: 583
  issue: 4
  year: 2011
  end-page: 95
  article-title: Chronic stress, cognitive functioning and mental health
  publication-title: Neurobiol Learn Mem.
– volume: 289
  start-page: 2651
  issue: 20
  year: 2003
  end-page: 62
  article-title: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial
  publication-title: JAMA.
– volume: 48
  year: 2022
  article-title: The S1PR2‐CCL2‐BDNF‐TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia
  publication-title: Neuropathol Appl Neurobiol.
– volume: 444
  start-page: 486
  issue: 7118
  year: 2006
  end-page: 9
  article-title: Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
  publication-title: Nature.
– volume: 30
  start-page: 225
  issue: 3
  year: 2005
  end-page: 42
  article-title: Stress hormones and human memory function across the lifespan
  publication-title: Psychoneuroendocrinology.
– ident: e_1_2_19_62_1
  doi: 10.1523/JNEUROSCI.1715-07.2007
– ident: e_1_2_19_129_1
  doi: 10.1016/j.bbi.2016.02.001
– volume: 46
  start-page: 977
  issue: 5
  year: 1994
  ident: e_1_2_19_47_1
  article-title: Correlation of neuroactive steroid modulation of [35S]t‐butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma‐aminobutyric acidA receptor function
  publication-title: Mol Pharmacol.
– ident: e_1_2_19_55_1
  doi: 10.1046/j.1365-201X.1998.0287f.x
– ident: e_1_2_19_100_1
  doi: 10.1038/nrn3587
– ident: e_1_2_19_121_1
  doi: 10.1016/j.neuropharm.2023.109530
– ident: e_1_2_19_122_1
  doi: 10.1016/j.neuropharm.2003.11.029
– ident: e_1_2_19_6_1
  doi: 10.1073/pnas.88.10.4553
– ident: e_1_2_19_58_1
  doi: 10.1007/s00213-008-1150-7
– ident: e_1_2_19_116_1
  doi: 10.1016/j.ejphar.2005.01.049
– ident: e_1_2_19_49_1
  doi: 10.1126/science.2422758
– ident: e_1_2_19_126_1
  doi: 10.1111/nan.12799
– ident: e_1_2_19_14_1
  doi: 10.1016/j.neuroscience.2006.07.031
– ident: e_1_2_19_134_1
  doi: 10.1007/s00213-005-0148-7
– volume: 72
  start-page: 1044
  issue: 6
  year: 2017
  ident: e_1_2_19_21_1
  article-title: Midlife work‐related stress increases dementia risk in later life: the CAIDE 30‐year study
  publication-title: J Gerontol B Psychol Sci Soc Sci.
– ident: e_1_2_19_107_1
  doi: 10.1111/cns.13926
– ident: e_1_2_19_19_1
  doi: 10.1093/brain/awq116
– ident: e_1_2_19_39_1
  doi: 10.1016/j.neuropharm.2008.07.045
– ident: e_1_2_19_138_1
  doi: 10.1038/nrendo.2013.31
– ident: e_1_2_19_63_1
  doi: 10.1016/S0887-6177(03)00096-9
– ident: e_1_2_19_44_1
  doi: 10.2165/00003495-199142030-00003
– ident: e_1_2_19_75_1
  doi: 10.1016/j.jsbmb.2004.12.001
– ident: e_1_2_19_22_1
  doi: 10.1096/fj.05-4265fje
– ident: e_1_2_19_78_1
  doi: 10.1016/j.yhbeh.2010.03.018
– ident: e_1_2_19_56_1
  doi: 10.1016/S0006-8993(02)02414-9
– ident: e_1_2_19_42_1
  doi: 10.1146/annurev.ne.17.030194.003033
– ident: e_1_2_19_27_1
  doi: 10.1016/S0028-3908(02)00172-7
– ident: e_1_2_19_16_1
  doi: 10.1016/j.nlm.2011.02.016
– ident: e_1_2_19_43_1
  doi: 10.1016/0165-6147(92)90142-S
– ident: e_1_2_19_97_1
  doi: 10.1016/j.yhbeh.2015.10.010
– ident: e_1_2_19_51_1
  doi: 10.1016/0166-4328(96)00004-6
– ident: e_1_2_19_86_1
  doi: 10.1126/science.290.5489.131
– ident: e_1_2_19_103_1
  doi: 10.1016/j.neuint.2006.02.002
– ident: e_1_2_19_96_1
  doi: 10.1016/j.pneurobio.2013.08.004
– ident: e_1_2_19_34_1
  doi: 10.1038/s41398‐020‐01027‐6
– ident: e_1_2_19_93_1
  doi: 10.3233/JAD-2012-120268
– ident: e_1_2_19_118_1
  doi: 10.1016/S0006-8993(03)02939-1
– ident: e_1_2_19_80_1
  doi: 10.1016/0306-4530(90)90025-5
– ident: e_1_2_19_61_1
  doi: 10.1007/s00213-005-0254-6
– ident: e_1_2_19_17_1
  doi: 10.1001/archgenpsychiatry.2010.61
– ident: e_1_2_19_8_1
  doi: 10.1016/j.ynstr.2019.100206
– ident: e_1_2_19_50_1
  doi: 10.1016/S0165-0173(01)00124-2
– ident: e_1_2_19_35_1
  doi: 10.1016/j.neuroscience.2011.03.061
– ident: e_1_2_19_66_1
  doi: 10.1016/0376-8716(87)90029-9
– ident: e_1_2_19_77_1
  doi: 10.1007/s00213-011-2322-4
– ident: e_1_2_19_40_1
  doi: 10.1016/S0301-0082(02)00013-8
– ident: e_1_2_19_79_1
  doi: 10.1210/endo-81-2-369
– ident: e_1_2_19_92_1
  doi: 10.1038/319774a0
– ident: e_1_2_19_99_1
  doi: 10.1016/j.neuint.2011.10.003
– ident: e_1_2_19_111_1
  doi: 10.1155/2022/3618090
– ident: e_1_2_19_76_1
  doi: 10.1016/j.nlm.2010.01.002
– ident: e_1_2_19_20_1
  doi: 10.1016/j.jalz.2011.03.001
– volume: 10
  start-page: 38
  issue: 1
  year: 2013
  ident: e_1_2_19_94_1
  article-title: Brief but chronic increase in allopregnanolone causes accelerated AD pathology differently in two mouse models
  publication-title: Curr Alzheimer Res.
– ident: e_1_2_19_131_1
  doi: 10.1186/s40659-017-0130-y
– ident: e_1_2_19_137_1
  doi: 10.1016/S0140-6736(18)31551-4
– ident: e_1_2_19_53_1
  doi: 10.1124/jpet.110.169854
– ident: e_1_2_19_74_1
  doi: 10.1016/j.jsbmb.2009.11.007
– ident: e_1_2_19_48_1
  doi: 10.1016/0896-6273(90)90202-Q
– ident: e_1_2_19_10_1
  doi: 10.1016/j.psyneuen.2009.08.011
– ident: e_1_2_19_12_1
  doi: 10.1016/j.psyneuen.2019.05.028
– ident: e_1_2_19_95_1
  doi: 10.1371/journal.pone.0024293
– ident: e_1_2_19_82_1
  doi: 10.1124/pr.108.00505
– ident: e_1_2_19_15_1
  doi: 10.1016/j.psyneuen.2004.08.003
– ident: e_1_2_19_68_1
  doi: 10.3988/jcn.2008.4.3.99
– ident: e_1_2_19_60_1
  doi: 10.1016/j.pnpbp.2004.06.001
– ident: e_1_2_19_28_1
  doi: 10.1007/s00213-016-4258-1
– ident: e_1_2_19_65_1
  doi: 10.1007/s40263-018-0535-3
– ident: e_1_2_19_23_1
  doi: 10.1002/hipo.20790
– ident: e_1_2_19_130_1
  doi: 10.1016/S0165-5728(98)00264-1
– ident: e_1_2_19_71_1
  doi: 10.1001/jama.289.20.2651
– ident: e_1_2_19_112_1
  doi: 10.1016/j.yfrne.2017.07.002
– ident: e_1_2_19_25_1
  doi: 10.1016/j.coemr.2022.100359
– ident: e_1_2_19_46_1
  doi: 10.1113/jphysiol.1992.sp019020
– ident: e_1_2_19_132_1
  doi: 10.3389/fncel.2014.00115
– ident: e_1_2_19_26_1
  doi: 10.1016/j.biopsycho.2004.08.003
– ident: e_1_2_19_67_1
  doi: 10.1111/jgs.15358
– ident: e_1_2_19_85_1
  doi: 10.2174/1568007033482779
– ident: e_1_2_19_105_1
  doi: 10.1002/hep.1840110524
– ident: e_1_2_19_110_1
  doi: 10.1016/j.neuint.2010.03.012
– ident: e_1_2_19_59_1
  doi: 10.1097/00019052-199608000-00007
– ident: e_1_2_19_84_1
  doi: 10.1523/JNEUROSCI.22-13-05572.2002
– ident: e_1_2_19_98_1
  doi: 10.1111/j.1476-5381.2010.01059.x
– ident: e_1_2_19_104_1
  doi: 10.1007/978-1-4615-5945-0_7
– ident: e_1_2_19_113_1
  doi: 10.1016/j.pneurobio.2013.07.005
– volume: 241
  start-page: 346
  issue: 1
  year: 1987
  ident: e_1_2_19_139_1
  article-title: Structure‐activity relationships for steroid interaction with the GABA‐A receptor complex
  publication-title: J Pharmacol Exp Ther.
– ident: e_1_2_19_106_1
  doi: 10.1111/bpa.12196
– ident: e_1_2_19_38_1
  doi: 10.1111/j.1749-6632.1999.tb11341.x
– ident: e_1_2_19_91_1
  doi: 10.1006/nlme.1999.3927
– ident: e_1_2_19_5_1
  doi: 10.1016/j.ejphar.2007.11.071
– ident: e_1_2_19_45_1
  doi: 10.1111/j.1530-0277.1995.tb01496.x
– ident: e_1_2_19_9_1
  doi: 10.1016/j.psyneuen.2004.02.003
– volume: 50
  start-page: 291
  issue: 2
  year: 1998
  ident: e_1_2_19_37_1
  article-title: International Union of Pharmacology. XV. Subtypes of γ‐aminobutyric AcidA receptors: classification on the basis of subunit structure and receptor function
  publication-title: Pharmacol Rev.
– ident: e_1_2_19_135_1
  doi: 10.1016/j.jhep.2021.03.012
– ident: e_1_2_19_109_1
  doi: 10.1016/0006-8993(95)01244-3
– ident: e_1_2_19_128_1
  doi: 10.1111/j.1365-2982.2008.01132.x
– ident: e_1_2_19_87_1
  doi: 10.1111/j.1600-0404.1984.tb07807.x
– ident: e_1_2_19_120_1
  doi: 10.1016/S0074-7742(01)46066-1
– ident: e_1_2_19_7_1
  doi: 10.1046/j.1471-4159.2000.0750732.x
– ident: e_1_2_19_11_1
  doi: 10.1002/hbm.21502
– ident: e_1_2_19_36_1
  doi: 10.1038/nrn1703
– ident: e_1_2_19_127_1
  doi: 10.1053/j.gastro.2008.12.057
– ident: e_1_2_19_124_1
  doi: 10.1016/j.bbi.2017.12.013
– ident: e_1_2_19_3_1
  doi: 10.1016/j.psyneuen.2023.106054
– ident: e_1_2_19_83_1
  doi: 10.1186/s43141‐021‐00224‐0
– ident: e_1_2_19_102_1
  doi: 10.1023/A:1021949616422
– ident: e_1_2_19_2_1
  doi: 10.1016/j.jalz.2017.02.001
– volume: 288
  start-page: 679
  issue: 2
  year: 1999
  ident: e_1_2_19_88_1
  article-title: Finasteride, a 5alpha‐reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice
  publication-title: J Pharmacol Exp Ther.
– ident: e_1_2_19_90_1
  doi: 10.1016/S0166-4328(01)00399-0
– ident: e_1_2_19_115_1
  doi: 10.1021/jm00307a026
– ident: e_1_2_19_4_1
  doi: 10.1371/journal.pone.0111136
– ident: e_1_2_19_70_1
  doi: 10.1001/jama.285.11.1489
– ident: e_1_2_19_123_1
  doi: 10.1152/ajpgi.00073
– ident: e_1_2_19_29_1
  doi: 10.1007/s00213-018-4864-1
– ident: e_1_2_19_18_1
  doi: 10.3390/biom12091262
– ident: e_1_2_19_54_1
  doi: 10.1111/j.1748-1716.1987.tb08202.x
– ident: e_1_2_19_57_1
  doi: 10.1016/0006-8993(93)91524-V
– ident: e_1_2_19_52_1
  doi: 10.1111/j.1600-0773.1987.tb01770.x
– ident: e_1_2_19_32_1
  doi: 10.1016/j.brainresrev.2005.11.001
– ident: e_1_2_19_81_1
  doi: 10.1016/j.psyneuen.2022.105754
– ident: e_1_2_19_73_1
  doi: 10.1212/01.wnl.0000339036.88842.9e
– ident: e_1_2_19_117_1
  doi: 10.1046/j.1365-201x.2000.00744.x
– ident: e_1_2_19_114_1
  doi: 10.1038/nature05324
– ident: e_1_2_19_89_1
  doi: 10.1016/j.npep.2019.101937
– ident: e_1_2_19_72_1
  doi: 10.1001/jama.291.24.2947
– ident: e_1_2_19_108_1
  doi: 10.1016/j.pharmthera.2021.108048
– ident: e_1_2_19_30_1
  doi: 10.1007/s00213-014-3776-y
– ident: e_1_2_19_31_1
  doi: 10.1016/j.psyneuen.2012.10.014
– ident: e_1_2_19_33_1
  doi: 10.1016/j.coph.2006.11.005
– ident: e_1_2_19_69_1
  doi: 10.1001/jama.279.9.688
– ident: e_1_2_19_119_1
  doi: 10.1111/j.1460-9568.2004.03610.x
– ident: e_1_2_19_101_1
  doi: 10.1016/j.abb.2013.04.005
– ident: e_1_2_19_41_1
  doi: 10.1111/bph.13843
– ident: e_1_2_19_133_1
  doi: 10.1038/s41598-018-37409-6
– ident: e_1_2_19_64_1
  doi: 10.1192/bjp.159.2.213
– ident: e_1_2_19_125_1
  doi: 10.1111/apha.13270
– ident: e_1_2_19_136_1
  doi: 10.1111/j.1365-2044.1990.tb14683.x
– ident: e_1_2_19_24_1
  doi: 10.1515/revneuro-2014-0035
– ident: e_1_2_19_13_1
  doi: 10.1016/S0006-8993(97)00455-1
SSID ssj0013060
Score 2.4679434
SecondaryResourceType review_article
Snippet The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 281
SubjectTerms Acetic acid
Aged
allopregnanolone
Alzheimer Disease - drug therapy
Alzheimer's disease
Animal cognition
Animals
Central nervous system
Cognition
Cognitive ability
Cognitive Dysfunction - drug therapy
dementia
Dementia disorders
GABA-A receptor
gamma-Aminobutyric Acid - pharmacology
Hepatic encephalopathy
Humans
Impairment
Medroxyprogesterone acetate
Memory
Neurodegenerative diseases
Neurosteroids
Neurosteroids - therapeutic use
Pregnanolone
Pregnanolone - pharmacology
Receptors
Receptors, GABA-A
Steroid hormones
Steroids
Transgenic animals
γ-Aminobutyric acid
Title The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13705
https://www.ncbi.nlm.nih.gov/pubmed/37518841
https://www.proquest.com/docview/2849624409
https://www.proquest.com/docview/2844089051
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-212756
Volume 294
WOSCitedRecordID wos001039236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1365-2796
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013060
  issn: 1365-2796
  databaseCode: WIN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1365-2796
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013060
  issn: 1365-2796
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5VLUJcoPy1gVIZgZBABMVrb2xLXBbKQhFdKkRhb5YdO1UkuoHdLmcegifskzB2soYKhIQ4JEriiWLZM5nPnvFngPvOFsz5WuKwxFgcoFCXG6FUTodCWVPTqmY2bjYhJhM5narDNXi6WgvT8UOkCbdgGfF_HQzc2MWvRt42J08oE4HAdINSJsPGDQN--DOGUMQ1wogheF6io-vJSWMeT3r3vDv6DWMmAtHz2DU6n_GV_6v2JlzuQScZdVpyFdb87BpcPOjD6tfhCyoLeTl6NiIdsfNjYgjCbdKliRPEtSTG4LvZPWKOTYOokqTUIxLWWjbzMNF49u37qse9I2GWl0TKTBP_qyTQMrSNW9yAo_GL989f5f1eDHmFEGOY14zzypQS8YCshC-YEfikthU1zhSiLjmVhrl6oJysjWHec2WZLQZWKc-pZzdhfdbO_DYQKj333Do8FA7PhGSeDStvraPCcmUyeLjqEl31ROVhv4xPOg1YsA11bMMM7iXZzx09xx-ldlY9q3sTXWj0y6pEcFOoDO6mYjSuEDExM98uowwvZKAwy2Cr04j0GRYCVpJjyYNORVJJYOzeaz6MdDs_1suTpY4s-mUGj6Ji_KWi-vXb_YN4detfhG_DpQFiry71bQfWT-dLfwcuVF9Pm8V8N1oFnsVU7sLG3rvx0Ru8-7g_-QGk9xZO
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6hgqAXym8JFDACIVE1KF57Y_u4_JQudBcOBXqz7NipItEN7HY58xB9Qp6EsZ0NVCAkxCFSFE8Uy57JfJ4ZfwZ45GzBnK8lLkuMxQUKdbkRSuV0KJQ1Na1qZuNhE2I6lYeH6l1XmxP2wiR-iD7gFiwj_q-DgYeA9K9W3jbHTykTgcH0PEekEU5u-Die_kwiFHGTMIIInpfo6Tp20ljI07971h_9BjJ7BtGz4DV6n92N_-z3FbjcwU4ySnpyFc752TW4OOkS69fhC6oLeTV6NiKJ2nmHGIKAm6RCcYLIlsQsfIrvEXNkGsSVpC8-ImG3ZTMPocbv305Xc-4dCXFeEkkzTfyzkkDM0DZucQPe7748eL6Xd6cx5BWCjGFeM84rU0pEBLISvmBG4JPaVtQ4U4i65FQa5uqBcrI2hnnPlWW2GFilPKee3YS1WTvzt4BQ6bnn1uGlcIEmJPNsWHlrHRWWK5PBk9Wc6KqjKg8nZnzS_ZIFx1DHMczgYS_7ORF0_FFqazW1ujPShUbPrEqEN4XK4EHfjOYVciZm5ttllOGFDCRmGWwmleg_w0LKSnJseZx0pG8JnN0vmg8j3c6P9PJ4qSOPfpnBdtSMv3RUv347nsS72_8ifB8u7R1M9vX-ePrmDqwPEImlQrgtWDuZL_1duFB9PWkW83vRRH4AB_AXDw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwED-hDk28wPgf2MAIhAQiKK7d2n7sKIXBVibEpr1ZduxMkVgz2pVnPsQ-IZ-Es50GJhAS4iFSFF8Uy77L_c53_hngibMFc76SGJYYiwEKdbkRSuV0IJQ1FS0rZuNhE2I6lUdHar-tzQl7YRI_RLfgFiwj_q-DgftTV_1q5U198pIyERhM13g4RaYHa-OPk4Pdn2mEIm4TRhjB8yH6upafNJbydG9f9Ei_wcyOQ_QifI3-Z3LtP3u-AVdb4ElGSVOuwyU_uwHre21q_SZ8QYUhb0bbI5LInV8QQxByk1QqThDbkpiHTyt8xBybGpEl6cqPSNhvWc_DYuP3b-erWfeOhJVeEmkzTfy3kkDN0NRucQsOJq8_vXqbt-cx5CXCjEFeMc5LM5SICWQpfMGMwCeVLalxphDVkFNpmKv6ysnKGOY9V5bZom-V8px6dht6s2bm7wKh0nPPrcNLYYgmJPNsUHprHRWWK5PBs9Wc6LIlKw9nZnzWXdCCY6jjGGbwuJM9TRQdf5TaXE2tbs10odE3o9pwjHEzeNQ1o4GFrImZ-WYZZXghA41ZBneSSnSfYSFpJTm2PE060rUE1u5xfTjSzfxYL0-WOjLpDzN4HjXjLx3V7z7s7MW7e_8i_BDW98cTvbszfX8frvQRiqVKuE3onc2Xfgsul1_P6sX8QWsjPwDW_Re4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+GABA+system%2C+a+new+target+for+medications+against+cognitive+impairment%E2%80%94Associated+with+neuroactive+steroids&rft.jtitle=Journal+of+internal+medicine&rft.au=B%C3%A4ckstr%C3%B6m%2C+Torbj%C3%B6rn&rft.au=Turkmen%2C+Sahruh&rft.au=Das%2C+Roshni&rft.au=Doverskog%2C+Magnus&rft.date=2023-09-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=294&rft.issue=3&rft.spage=281&rft.epage=294&rft_id=info:doi/10.1111%2Fjoim.13705&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_joim_13705
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon